Oak Ridge Investments LLC Oyster Point Pharma, Inc. Transaction History

Oak Ridge Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$3.6 - $11.2 $145,173 - $451,651	-40,326 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$8.58 - $17.65 $166,675 - $342,868	-19,426 Reduced 32.51%	40,326 $469,000
Q4 2021 Feb 01, 2022	SELL	$10.17 - $18.96 $46,680 - $87,026	-4,590 Reduced 7.13%	59,752 $1.09 Million
Q3 2021 Nov 05, 2021	SELL	$11.67 - $18.07 $20,492 - $31,730	-1,756 Reduced 2.66%	64,342 $763,000
Q2 2021 Jul 30, 2021	SELL	$16.25 - $21.51 $118,023 - $156,227	-7,263 Reduced 9.9%	66,098 $1.14 Million
Q1 2021 May 12, 2021	SELL	$17.92 - $25.86 $9.11 Million - $13.1 Million	-508,100 Reduced 87.38%	73,361 $1.34 Million
Q1 2021 May 04, 2021	BUY	$17.92 - $25.86 $9.13 Million - $13.2 Million	509,596 Added 709.1%	581,461 $10.6 Million
Q4 2020 Feb 03, 2021	SELL	$18.13 - $25.18 $328,624 - $456,412	-18,126 Reduced 20.14%	71,865 $1.35 Million
Q3 2020 Nov 12, 2020	SELL	$17.83 - $29.12 $132,566 - $216,507	-7,435 Reduced 7.63%	89,991 $1.9 Million
Q2 2020 Aug 05, 2020	BUY	$27.86 - $35.93 $2.71 Million - $3.5 Million	97,426 New	97,426 $2.81 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Ridge Investments LLC with notifications on news.